• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The updated GRAPPA and EULAR recommendations for the management of psoriatic arthritis: Similarities and differences.

作者信息

Coates Laura, Gossec Laure

机构信息

Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.

Sorbonne Université, Inserm, Institut Pierre Louis d'Epidémiologie et de Santé Publique, 75013 Paris, France; Rheumatology department, AP-HP, Pitié-Salpêtrière hospital, 75013 Paris, France.

出版信息

Joint Bone Spine. 2023 Jan;90(1):105469. doi: 10.1016/j.jbspin.2022.105469. Epub 2022 Sep 29.

DOI:10.1016/j.jbspin.2022.105469
PMID:36184036
Abstract
摘要

相似文献

1
The updated GRAPPA and EULAR recommendations for the management of psoriatic arthritis: Similarities and differences.银屑病关节炎管理的GRAPPA和EULAR更新推荐：异同点
Joint Bone Spine. 2023 Jan;90(1):105469. doi: 10.1016/j.jbspin.2022.105469. Epub 2022 Sep 29.
2
GRAPPA 2023: Major Projects, Key Advances, and Milestones.GRAPPA 2023：重大项目、关键进展和里程碑。
J Rheumatol. 2024 Oct 1;51(Suppl 2):65-69. doi: 10.3899/jrheum.2024-0266.
3
Basic Science Session 1. Biomarkers for Psoriatic Arthritis Treatment Response and Joint Damage Progression: An Update on 2 Industry-GRAPPA Projects.基础科学分会 1 场。银屑病关节炎治疗反应和关节损伤进展的生物标志物：2 项行业-GRAPPA 项目的最新进展。
J Rheumatol. 2022 Jun;49(6 Suppl 1):13-15. doi: 10.3899/jrheum.211320. Epub 2022 Apr 1.
4
GRAPPA 2021 Treatment Recommendations for Psoriatic Arthritis.GRAPPA 2021 治疗银屑病关节炎推荐意见。
J Rheumatol. 2023 Nov;50(Suppl 2):31-32. doi: 10.3899/jrheum.2023-0522. Epub 2023 Jul 7.
5
Psoriasis and psoriatic arthritis educational initiatives: an update from the 2013 GRAPPA Annual Meeting.银屑病和银屑病关节炎教育倡议：来自2013年GRAPPA年会的最新消息
J Rheumatol. 2014 Jun;41(6):1240-3. doi: 10.3899/jrheum.140180.
6
GRAPPA 2022 Patient Research Partners Network Update: Managing Growth.GRAPPA 2022 患者研究伙伴网络更新：管理增长。
J Rheumatol. 2023 Nov;50(Suppl 2):23-24. doi: 10.3899/jrheum.2023-0519. Epub 2023 Jul 7.
7
The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 Annual Meeting: Report and Plan for Completing the Core Outcome Measurement Set.2018年年会的GRAPPA-OMERACT银屑病关节炎工作组：核心结局测量集的报告与完成计划
J Rheumatol Suppl. 2019 Jun;95:33-37. doi: 10.3899/jrheum.190122.
8
Challenges in the Diagnosis and Assessment of Psoriatic Arthritis.银屑病关节炎的诊断与评估中的挑战
J Rheumatol. 2022 Jun;49(6 Suppl 1):64-67. doi: 10.3899/jrheum.211337. Epub 2022 Apr 15.
9
Treatment of psoriatic arthritis: management recommendations.银屑病关节炎的治疗：管理建议。
Clin Exp Rheumatol. 2015 Sep-Oct;33(5 Suppl 93):S73-7. Epub 2015 Oct 15.
10
Defining Outcome Measures for Psoriatic Arthritis: A Report from the GRAPPA-OMERACT Working Group.银屑病关节炎结局指标的定义：GRAPPA-OMERACT工作组报告
J Rheumatol. 2017 May;44(5):697-700. doi: 10.3899/jrheum.170150.

引用本文的文献

1
Risk of Major Adverse Cardiovascular Events and Thromboembolism Events in Patients with Psoriatic Arthritis on JAK Inhibitors: A Network Meta-Analysis.接受JAK抑制剂治疗的银屑病关节炎患者发生主要不良心血管事件和血栓栓塞事件的风险：一项网状Meta分析
Rheumatol Ther. 2025 Jul 19. doi: 10.1007/s40744-025-00783-5.
2
Ixekizumab Retention Rate and Predictors of Treatment Persistence in Psoriatic Arthritis: Results of an Italian Multicenter Study.司库奇尤单抗在银屑病关节炎中的留存率及治疗持续性的预测因素：一项意大利多中心研究的结果
J Psoriasis Psoriatic Arthritis. 2025 May 13:24755303251342503. doi: 10.1177/24755303251342503.
3
Navigating Psoriatic Arthritis: Treatment Pathways and Patient-Specific Strategies for Improved Outcomes.
银屑病关节炎的应对之道：改善治疗效果的治疗途径及个性化策略
Drugs. 2025 May 11. doi: 10.1007/s40265-025-02192-y.
4
A review on anterior uveitis and spondyloarthritis with a focus on the interdisciplinary approach between ophthalmologists and rheumatologists.一篇关于前葡萄膜炎与脊柱关节炎的综述，重点关注眼科医生与风湿病学家之间的跨学科方法。
Saudi J Ophthalmol. 2025 Jan 2;39(1):20-30. doi: 10.4103/sjopt.sjopt_240_24. eCollection 2025 Jan-Mar.
5
Changes in health related quality of life in mothers with inflammatory joint disease from year 2000 to 2020 - a comparative cross-sectional study.2000年至2020年炎症性关节病母亲健康相关生活质量的变化——一项比较性横断面研究。
Front Glob Womens Health. 2025 Jan 8;5:1458390. doi: 10.3389/fgwh.2024.1458390. eCollection 2024.
6
Refractory psoriatic arthritis: emerging concepts in whole process management.难治性银屑病关节炎：全程管理中的新观念
Clin Rheumatol. 2025 Feb;44(2):583-590. doi: 10.1007/s10067-024-07267-x. Epub 2025 Jan 14.
7
Efficacy and Safety of Bimekizumab in Patients With Psoriatic Arthritis With or Without Methotrexate: 52-Week Results From Two Phase 3 Studies.比美吉珠单抗治疗伴或不伴甲氨蝶呤的银屑病关节炎患者的疗效和安全性：两项3期研究的52周结果
ACR Open Rheumatol. 2024 Nov;6(11):720-731. doi: 10.1002/acr2.11727. Epub 2024 Jul 30.
8
Review: A Contemporary, Multifaced Insight into Psoriasis Pathogenesis.综述：对银屑病发病机制的当代多面洞察
J Pers Med. 2024 May 16;14(5):535. doi: 10.3390/jpm14050535.
9
Two sides of management recommendations for psoriatic arthritis.银屑病关节炎管理建议的两个方面。
Nat Rev Rheumatol. 2024 Jul;20(7):397-398. doi: 10.1038/s41584-024-01127-3.
10
Identification and characteristics of patients with potential difficult-to-treat psoriatic arthritis: exploratory analyses of the Greek PsA registry.识别和评估潜在难治性银屑病关节炎患者的特征：希腊银屑病关节炎注册研究的探索性分析。
Rheumatology (Oxford). 2024 Sep 1;63(9):2427-2432. doi: 10.1093/rheumatology/keae263.